Tipificação sanguínea em cães AEC 1 positivo: análise comparativa entre a imunocromatografia, hemoaglutinação e citometria de fluxo by Santos, Suzana Claudia Spinola et al.
Braz J Vet Res Anim Sci. 2020;57(1):e151444
https://doi.org/10.11606/issn.1678-4456.bjvras.2020.151444
FULL ARTICLE
ISSN Online 1678-4456
Blood typing in positive DEA 1 dogs: comparative analysis between 
immunochromatography, hemagglutination and flow cytometry
Tipificação sanguínea em cães AEC 1 positivo: análise comparativa entre 
a imunocromatografia, hemoaglutinação e citometria de fluxo
Suzana Claudia Spinola dos Santos1 ; Mariane Melo dos Santos2; Wellington Francisco Rodrigues3; 
Roberto Meyer2; Maria de Fátima Dias Costa4
1 Universidade Federal da Bahia, Instituto de Ciências da Saúde, Programa de Pós-graduação em Processos Interativos dos 
Órgãos e Sistemas, Salvador – BA, Brazil
2 Universidade Federal da Bahia, Instituto de Ciências da Saúde, Laboratório de Imunologia e Biologia Molecular, Salvador – BA, Brazil
3 Universidade Federal do Triângulo Mineiro, Programa de Pós-graduação em Ciências da Saúde/Biologia Celular, Uberaba – MG, Brazil
4 Universidade Federal da Bahia, Instituto de Ciências da Saúde, Laboratório de Neuroquímica e Biologia Celular, Salvador – BA, Brazil
ABSTRACT
Blood typing techniques have been improved to ensure greater safety for transfusion procedures. Typification for the DEA 
1 antigen through flow cytometry should offer more reliability to routine immunohematology in donor and recipient dogs. 
Currently, the DEA 1 group is starting to be an autosomal dominant allelic system with the DEA 1 negative type and its 
variations of positivity. The present study investigated the DEA 1 antigen using the techniques of immunochromatography, 
hemagglutination and flow cytometry. Among the positive animals for the DEA 1 group, typified by flow cytometry, 
medium intensities of fluorescence were found, which are indicative of weak, moderate and strong antigenicity. This 
enabled the division of the DEA 1 group into weak positive, moderate positive and strong positive. The blood typing 
techniques for the DEA 1 group by flow cytometry, agglutination and immunochromatography had positive (Spearman 
r=0.70) and statistically significant (p>0.0001) correlations.
Keywords: Typification in dogs. Canine transfusion medicine. Transfusion risk in dogs. Dog erythrocyte antigen 1. 
Flow cytometry.
RESUMO
As técnicas de tipificação sanguínea vêm sendo aperfeiçoadas para garantir maior segurança aos procedimentos transfusionais. 
A tipificação para o antígeno AEC 1 com o emprego da citometria de fluxo poderá oferecer mais confiabilidade à rotina 
da imunohematologia em cães doadores e receptores. Na atualidade, o grupo AEC 1 passou a ser denominado como um 
sistema alélico autossômico dominante com o tipo AEC 1 negativo e suas variações de positividade. O presente trabalho 
comparou os resultados de três técnicas utilizadas para a pesquisa do antígeno AEC 1: cromatografia; hemoaglutinação 
e citometria de fluxo. Dentro dos indivíduos positivos para o grupo AEC 1, tipificados pela citometria de fluxo, foram 
encontradas intensidades médias de fluorescência indicadoras de antigenicidade fraca, moderada e forte, podendo-se 
dividir o grupo AEC 1 em positivo fraco, positivo moderado e positivo forte. As técnicas de tipificação sanguínea para 
o grupo AEC 1 por cromatografia, hemoaglutinação e citometria de fluxo apresentaram correlação positiva (Spearman 
r=0,70) e estatisticamente significativa (p<0,0001).
Palavras-chave: Tipagem em cães. Medicina transfusional canina. Risco transfusional em cães. AEC 1. Citometria de fluxo. 
2/10
Braz J Vet Res Anim Sci. 2020;57(1):e151444
How to cite: Santos SCS, Santos MM, Rodrigues WF, 
Meyer R, Costa MFD. Blood typing in positive DEA 1 dogs: 
comparative analysis between immunochromatography, 
hemagglutination and flow cytometry. Braz J Vet Res 
Anim Sci. 2020;57(1):e151444. https://doi.org/10.11606/
issn.1678-4456.bjvras.2020.151444
Introduction
In current veterinary medicine, the safe practice of 
blood transfusions is achieving more prominence and 
pre-transfusion screening standards have been established for 
donor animals. It is known that for a safe blood transfusion 
it is important to make use of typified and compatible blood 
(Giger, 2014; Tocci & Ewing, 2009).
According to Giger (2014), the DEA 1 system is an 
exception among other positive and negative systems, 
such as DEA 3, DEA 4, DEA 5, DEA 7 and Dal, then it is 
subdivided into DEA 1.1 (A1) and DEA 1.2 (A2), which 
are apparently allelic, and another allele that would be DEA 
1.3 (A3). However, recent studies have indicated that it is 
more appropriate for DEA group 1 to be characterized 
as negative, weak positive, moderate positive and strong 
positive, rather than being subdivided into two or three 
subtypes (Euler et al., 2016; Lee et al., 2017).
Through recent typing by anti-DEA 1 monoclonal 
antibodies, the DEA 1 group is starting to be known as an 
autosomal dominant allelic system with the DEA 1 negative 
type and its variations of positivity (weak, medium and 
intense) (Acierno et al., 2014; Euler et al., 2016; Lee et al., 
2017; Polak et al., 2015).
Evaluating the DEA 1 blood group when typing 
53 positive DEA 1 dogs, Polak et al. (2015) subdivided it 
into positive weak DEA 1, positive moderate DEA 1 and 
positive strong DEA 1. Thus, it is consistent information that 
this model is dependent on an autosomal dominance with 
4 to 5 alleles: AEC 1 negative (0), AEC 1 positive weak (1+), 
AEC 1 positive moderate (2+) and AEC 1 positive (3+ and 4+), 
comparing the findings of the reaction intensities of 
immunochromatographic strips to the mean values of 
fluorescence by the technique of typification by flow cytometry, 
a quantitative technique. Euler et al. (2016) also found a 
strong correlation between the visual and densitometric 
semi-quantitative results of the degrees of positivity of the 
AEC group 1 in weak, moderate and strong.
The blood typing of dogs, in general, is based on the 
serological identification by agglutination reactions. Originally, 
the serum of sensitized dogs was used for typing, through 
polyvalent alloantibodies, which vary among groups of 
animals due to the intensity of individual antigenicity of 
these animals (Chang et al., 2006; Giger et al., 2005). So, the 
recognition of the DEA 1 blood group is still made through 
polyclonal antibodies obtained by canine alloimmunization 
(Blais et al., 2007; Chang et al., 2006).
The present investigation analyzed the DEA 1 antigen 
using the flow cytometry and agglutination technique 
in 69 dogs of different breeds, aged between one and 
eight years, weighing from 28 kg up, and of both sexes, 
all positive by immunochromatography. Through the 
correlation between the three techniques, it is possible to 
identify each positivity score in DEA 1 positive animals, 
and to classify it as weak, moderate and strong. The blood 
typing techniques have been improved to ensure greater 
safety for transfusion procedures. The three techniques 
were compared to establish scores of the intensities of the 
reactions found in flow cytometry and agglutination in 
dogs positive by immunochromatography.
In veterinary transfusion medicine, the gold-standard 
technique for blood typing has not yet been established 
and the aim is to contribute to this goal.
Materials and Methods
In order to carry out the hemagglutination tests and 
the flow cytometry, samples of canine antisera from 
post-transfused dogs with DEA 1 blood type were submitted 
to the investigation of antibodies by flow cytometry as a 
follow-up of alloimmunization of these respective dogs 
(Santos et al., 2018). Each antiserum had its own average 
fluorescence intensity, ranging from 15 to 538.99 and 
representing the concentrations of anti-DEA 1 antibodies. 
When they were unified to form an antiserum pool, it 
presented a higher average fluorescence intensity, which 
was 979.52, demonstrating antiserum potentiation.
This antiserum pool was diluted in the ratio of 1:2, 
which was the titration that showed good hemagglutination 
reaction with blood known as DEA 1, because at higher 
dilution no hemagglutination was found in the crossmatching 
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tests in tubes. When submitted to the new evaluation by 
flow cytometry, it presented an average fluorescence of 
623.24. This procedure was adopted so that no prozone 
effect occurred, with an antibody concentration higher 
than that of the antigen (Acierno et al., 2014; Hohenhaus, 
2004; Stieger et al., 2005; Vap, 2010).
In order to perform the flow cytometry, the cytometer 
Becton Dickinson FACSCalibur™ interconnected to a PC 
Power Macintosh (Apple, Salvador, BA, Brazil, Laboratory 
of Immunology of the Federal University of Bahia) was used 
along with the instrument-specific software (BD CellQuest 
Pro™ software, Becton, Dickinson and Company).
The immunochromatography tests were performed 
using the commercial kit for the detection of DEA 1 blood 
group Alvedia (Limonest, France), following the method 
provided by the manufacturer. Three drops of the buffer 
solution were placed in the tube, followed by 3 μL of whole 
blood with 5% EDTA. After homogenization for 7 sec, the 
samples were deposited in the strips for evidence of reaction 
or non-reaction followed by reading.
The samples tested underwent three washes with 
saline solution and a red cell concentrate of 4%. For one 
drop of the erythrocyte concentrate, two drops of the 
anti-DEA 1 polyclonal antiserum were added. This method 
followed the principle of reverse typing, in which the method 
of the test of crossmatching in tubes is carried out when 
the standard serum is an antiserum known as a specific 
anti-erythrocyte antigen. In this case, it contained anti-DEA 
1 antibodies (Lacerda, 2005). The results were determined 
by the cross-intensity score, according to Gibson (2007).
For the flow cytometric typing of each blood sample, 
2 mL of whole blood in EDTA was centrifuged at 
2200 x g for 3 min. The plasma was discarded, and the red 
blood cell concentrate was resuspended with saline in the 
same volume as the discarded plasma. Subsequently, 2 μL 
of concentrate were mixed with 998 μL of saline solution 
and homogenized in vortex and then reserved for the test. 
50 μL of the antiserum, interacting with the erythrocyte 
with the positive DEA 1 on its surface, and 50 μL of serum 
free from alloantibodies, representing the negative control, 
which did not interact with binding to erythrocytes DEA 
1 positive or negative, were incubated at 56 °C for 10 min. 
Then there was a second incubation with 40 μL of the solution 
of erythrocytes to be tested diluted at room temperature 
for 30 min. The polyclonal anti-DEA 1 serum samples and 
the negative control with the erythrocyte suspension were 
washed with saline solution at 2200 x g for 3 min, 3 times. 
Positive and negative controls were also added to the vials, 
plus 3 μL of anti-dog IgG antibody at room temperature 
sheltered from light for 30 min. The sera were then twice 
washed with saline solution at 2200 x g for 3 minutes. Then, 
all vials were resuspended in 300 μL of saline and, finally, the 
readings were taken on the cytometer (Santos et al., 2018).
For the comparative analysis of the three techniques, a 
Spearman test was performed, and all variables were analyzed 
by Pearson’s chi-square test. For the tables mean, standard 
deviation, median, minimum value, maximum value and 
variance by the program EXCEL, version 2013 were applied. 
The graphs were created using the GRAPH PAD PRISM 
program (GraphPad, 2018).
Results
During the standardization of positive and negative results, 
typing tests were performed by flow cytometry in animals 
that had already been typified by immunochromatography, 
where the lowest fluorescence mean value was 5.92 and the 
highest was 31.53 in nine negative animals that were being 
tested. For positive control, the flow cytometry technique 
was also performed in two animals known to be positive 
by immunochromatography, finding the mean fluorescence 
value of 979.52 and 623.24. Thus, the one with the highest 
value was chosen as positive control. Figure 1 shows the 
histograms of the negative and positive controls, while 
Figure 2 shows the histograms of the minimum and maximum 
fluorescence average results of the negative animals in the 
study, as well as the positive animals.
The group of 69 animals in the study were typified 
using the immunochromatography technique. Typing by 
flow cytometry and agglutination was also done, following 
the method of the crossmatching test in tubes, with the 
anti-seizure agent known as anti-DEA1. Of the 69 animals 
in this analysis typified by immunochromatography, 30 were 
negative and 39 were positive for the DEA 1 blood group. 
Table 1 shows the mean fluorescence and hemagglutination 
averages of the DEA 1 negative animals, where the fluorescence 
averages ranged from 5.92 to 71.46 and all presented 
negative hemoagglutination (Score 0). Table 2 shows the 
profile of the fluorescence averages of the DEA 1 positive 
animals, whose values ranged from 77.65 to 2391.82, and 
their agglutination scores were 1 to 3 crosses (1+, 2+, 3+) 
without any score 4 crosses (4+). The results of fluorescence 
averages in immunochromatography and flow cytometry 
of the 39 positive DEA 1 animals were compared with the 
agglutination scores and are presented in Table 3.
After establishing the respective cutoff points for 
positive and negative values, positivity and negativity were 
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Figure 1 – Sequence of the negative and positive controls analysis with the primary anti-DEA 1 negative and positive sera in graphs 
of size and granularity of erythrocytes and individual histograms. (A) Negative control obtained with lower fluorescence 
mean (5.92) from negative erythrocytes for the DEA1 group; (B) Negative control obtained with the highest fluorescence 
mean (31.53) from negative erythrocytes for the DEA1 group, with DEA1 negative animal serum; (C) Positive control 
obtained from animal known from the DEA1 group (979.52), representing positive erythrocytes with DEA1 negative 
animal serum. M1 = Marker peak; FSC = Forware SCatter; FITC = Fluorescein Isothiocyanate.
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Figure 2 – Sequence of graphs in size and granularity of erythrocytes and individual histograms, of erythrocytes negative for 
animals studied and positive for group DEA 1, which presented minimum and maximum values of fluorescence. 
(A) Negative animal for the DEA1 group, showing the lowest fluorescence mean of the negative animal’s group (7.67); 
(B) Negative animal for the DEA1 group, showing the highest fluorescence mean of the negative animal’s group (71.46); 
(C) DEA1-positive animal with serum exhibiting the lowest fluorescence mean of the group of positive animals (77.65) 
and representing the fluorescence closest to the established cut-off point (71.47); (D) Positive animal for the DEA1 
group, showing the highest fluorescence mean of the positive animal group (2391.82) M1 = Marker peak; FSC = Forware 
SCatter; FITC = Fluorescein Isothiocyanate.
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detected using the three different methods: flow cytometry, 
immunochromatography and hemagglutination, and they 
were compared for sensitivity (Figure 3). After evaluation of 
the data, no differences were found regarding the sensitivity 
of detection of positive and negative sera (p> 0.05).
Due to the variability of the agglutination intensity, as 
well as the values found in the immunochromatography, 
Table 1 – Comparison of mean fluorescence intensity (MFI) values 
obtained in flow cytometry with hemagglutination 
(agglutination score 0, 1+, 2+, 3+, 4+) of the animals 
that had negative results in blood typing by the group 
immunochromatography DEA 1 (n=30) – Salvador – 2017
Animal MFI Agglutination
1 31.53 0
2 12.77 0
3 5.92 0
4 8.24 0
5 9.44 0
6 9.76 0
7 7.67 0
8 8.37 0
9 8.35 0
10 28.51 0
11 71.46 0
12 43.26 0
13 20.49 0
14 14.11 0
15 13.45 0
16 9.41 0
17 9.87 0
18 17.62 0
19 36.49 0
20 15.25 0
21 52.8 0
22 43.1 0
23 61.8 0
24 68.32 0
25 30.21 0
26 49.47 0
27 23.35 0
28 16.13 0
29 30.39 0
30 26.24 0
Average 26.126
Stardard Deviation 19.23265
Medium 11.43
Minimum 5.92
Maximum 71.46
Variance 369.8949
(n) = 30 animals. Average and Stardard Deviation (Pearson; p <0.0001).
Table 2 – Comparison of mean fluorescence intensity (MFI) values 
obtained in flow cytometry with hemagglutination 
(agglutination score 0, 1+, 2+, 3+, 4+) of the animals 
that had positive results in blood typing by the group 
immunochromatography DEA 1 (n=39) – Salvador – 2017
Animal MFI Aglutinação
1 119.48 1
2 140.4 1
3 266.27 3
4 1421.43 1
5 250.54 1
6 240.21 1
7 91.51 1
8 174.01 1
9 316.11 2
10 127.54 1
11 226.52 3
12 293.4 3
13 270.91 3
14 123.96 1
15 187.83 1
16 2391.82 3
17 688.98 2
18 348.25 2
19 377.76 2
20 688.21 3
21 704.6 2
22 1592.5 3
23 1627.38 3
24 593.86 2
25 865.08 2
26 94.99 1
27 222.5 1
28 85.93 1
29 142.48 1
30 145.11 2
31 113.98 1
32 293.4 2
33 270.91 2
34 161.75 1
35 81.35 1
36 174.24 2
37 467.84 2
38 213.73 2
39 77.65 1
Average 427.5492
Standard Deviation 509.4232
Medium 240.21
Minimum 77.65
Maximum 2391.82
Variance 259511.9
(n) = 39 animals. Average and Standard Deviation (Pearson; p <0.0001).
there was a correlation for the positivity between the different 
methods (Figure 4). After the comparisons, there was a 
positive (Spearman r = 0.70), and statistically significant 
(p <0.0001) correlation, regarding the sensitivity of the tests.
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Figure 3 – Comparative analysis between the positive results of each 
technique for sensitivity. Note: After evaluation of the 
data, no differences were found regarding the sensitivity 
of detection of positive and negative sera (p> 0.05).
Figure 4 – Comparative analysis of quantitative values of positive 
hemoagglutination and flow cytometry. Note: After the 
comparisons, there is a positive (Spearman r = 0.70) 
and statistically significant (p <0.0001) correlation, 
regarding the sensitivity of the tests (***=p<0.0001).
Discussion
In the present work, the flow cytometry technique was 
used to detect the blood type of DEA 1 dogs. The results 
were compared with the immunochromatography technique 
and the hemagglutination technique.
Our results from the comparative analysis between 
immunochromatography, hemagglutination and flow 
cytometry were like those found by Acierno et al. (2014) 
when 66 dogs were typed by immunochromatography 
and flow cytometry, and the DEA 1 results in the 
immunochromatography were also positive for DEA 1 in 
flow cytometry. The Acierno et al. (2014) investigation used 
anti-DEA 1 murine monoclonal antibody as the primary 
antibody, conjugating to the polyclonal anti-murine secondary 
antibody of caprine origin, while in this study polyclonal 
antibody from alloimmunized dogs after blood transfusion 
with blood from the AEC 1 positive group was used as 
primary anti-DEA 1 antibody; and anti-canine polyclonal 
antibody of ovine origin was used as secondary antibody. 
Polyclonal primary antibodies were used demonstrating 
that the flow cytometry technique has high specificity as 
much as when using monoclonal antibodies.
The antiserum used here as a primary antibody in flow 
cytometry, which presented high concentration, was used 
as a polyclonal antibody to bind to the DEA 1 antigens in 
the crossmatching test in tubes (hemagglutination), and 
thus allowed to generate antigen-antibody reaction without 
the use of the Coombs canine antiglobulin reagent to 
obtain a better visualization of the agglutination. Blais et al. 
(2007) and Giger (2014) reported that initially the serum 
of sensitized dogs was used for typing, knowing that it 
was polyclonal serum, so that there could be variation 
between individuals and require the Coombs reagent for 
better visualization of the agglutination, but not always 
generating an excellent evaluation. In the present study, 
we did not observe in any sample the score of four crosses 
in agglutination, only the variation of one to three crosses, 
because in this method, the agglutinins produced have 
a poor reaction since we did not use Coombs reagent. 
Hara et al. (1991) identified the specificity of monoclonal 
antibodies when studying antibodies against type DEA 3, 
confirmed by cross-agglutination and using positive and 
negative erythrocytes. However, they found very low titles 
of 1:4 to 1:8 and with the reaction disappearing very quickly. 
In the present study, the maximum possible titration of the 
polyclonal antiserum for clumping was 1:2 without the aid 
of the Coombs reagent, like what Hara et al. (1991) found.
Table 3 – Distribution of animals with positive results in blood typing by DEA group 1, grouped by the obtained agglutination 
scores (1+, 2+, 3+), and then compared to the results of medium intensity of fluorescence (MIF) of flow cytometry 
(n=39) – Salvador – 2017 
No. of DEA 1+ animals
Agglutination MIF
Median Variance
Minimum Maximum Average S. D.
18 1+ 77.65 1421.43 214.3078 305.9991 133.97 93635.48
13 2+ 145.11 865.08 419.99 227.0188 348.25 51537.51
8 3+ 226.52 2391.82 919.6263 836.2198 490.805 699263.6
(n) = 39 animals. Average and Standard Deviation (Pearson; p <0.0001); No = Number; S.D. = Standard Deviation.
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The immunochromatography tests showed binding 
results ranging from strong to weak, which is expected 
in this technique. However, it was preferable not to 
categorize reactions as weak, moderate and strong as 
this was a test where the intensity positivity is visual, 
which leads to subjectivity of interpretation. Unlike the 
immunochromatography method used by Acierno et al. 
(2014), in which it was possible to quantify an intensity 
score of 0 to 4 crosses (0+, 1+, 2+, 3+, 4+) by reading the 
test strips in a densitometer, where 0+ and 1 + were negative 
and the following positives increased by antigenic intensity.
When the flow cytometric analyses were performed, a 
variation in bond reactions was found, which is revealed by the 
fluorescence averages. When compared to the results obtained 
in the hemagglutination, which followed the method of the 
test of crossmatching reaction, it was possible to categorize 
groups of 1+, 2+ and 3+ scores that were found, correlating 
them as shown in Table 3. Acierno et al. (2014) argued, from 
the results obtained in their studies with the flow cytometry 
technique for the diagnosis of DEA 1 blood group, that it is 
more appropriate to use a typing scheme in positive DEA 1 and 
negative DEA 1, with the detection of its weak, moderate, and 
strong antigen expression, thereby eliminating the poorly 
defined patterning of DEA 1.2 and DEA 1.3 blood types.
Lucidi et al. (2011), typing blood samples by flow cytometry 
with anti-DEA 1.1 monoclonal antibody in 62 DEA 1.1 negative 
dogs by tube typing technique, found (MIF) of fewer than 
25 (mean = 16 and median = 15) and 110 DEA 1.1 positive 
dogs also by tube typing found fluorescence averages greater 
than 73 (mean = 407 and median = 391). Goy-Thollot et al. 
(2017), typing DEA 1 animals with monoclonal antiserum, 
found an antigenic expression that they designated as negative 
DEA 1 which had less than 10 (MIF <10) in positive fraction 
of 10 ≤ MIF <100, moderate positive of 100 ≤ MIF <300 and 
strong positive with MIF ≥ 300. In the present study, the 
30 negative animals tested using immunochromatography 
and agglutination in the flow cytometry had anti-AEC 
1 polyclonal antibody lower than 71.46 (mean = 26.126 and 
median = 19.005); and the 39 positive animals, also using the 
same two techniques, had medium intensities of fluorescence 
higher than 77.65 (mean = 427.5492 and median = 240.21) 
in flow cytometry. When comparing the blood samples 
typed by immunochromatography with the same typified 
by flow cytometry, using the anti-DEA 1 primary antibody 
obtained by post-transfusion sensitization, a direct positive 
correlation was found as all presented positive results. 
Similarly, Euler et al. (2016), typing blood samples from dogs 
with monoclonal antibody by gel column, flow cytometry 
and immunochromatography, also obtained positive direct 
correlation results. This leads us to the conclusion that this 
antiserum had a high concentration of antibodies specific for 
the DEA group 1, even when it was an antiserum containing 
polyclonal antibodies. Comparing, Polak  et  al. (2015) 
carried out the re-establishment of animals considered to 
be negative DEA 1.1, positive DEA 1.1 and positive DEA 
1.2 using monoclonal and polyclonal antibodies in parallel 
to determine their correlation. They found in positive DEA 
1.1 animals a strong reaction when using antiserum to type 
DEA 1. In the same study, the negative DEA 1.1 samples tested 
by the monoclonal anti-DEA 1 antibody continued to present 
negative results, but when tested with polyclonal antibodies, 
weak to moderate DEA 1.1 were found. Surprisingly, six 
samples previously classified as positive DEA 1.2 were not 
in agreement with the results, with reactions of moderate 
variations with both the monoclonal and polyclonal reagents. 
In these samples, the results of moderate to strong positive 
DEA and negative DEA 1 were found.
Like the results from Lee et al. (2017) and Polak et al. 
(2015), the results found by flow cytometry in this work 
presented three groups of mean fluorescence intensity 
when compared with the scores obtained in agglutination. 
Lee et al. (2017), in a comparative study with the blood 
types Kai 1 and Kai 2, argued that the DEA 1 blood group 
is composed of a variation of DEA 1 types and not divided 
into DEA 1.1 and DEA 1.2. Polak et al. (2015), found it 
unusual to have two different proteins for DEA 1.1 and 
DEA 1.2 types as parts of the same blood group system. 
Simultaneously, through their flow cytometry research, 
they demonstrated that DEA 1.1 and DEA 1.2 are the same 
antigen and are not correlated with variations in group 
expression. It is a positive DEA 1 antigen with variations 
of weak, moderate and strong.
Safra et al. (2014), in preliminary studies of the canine 
genome, found only one nucleotide polymorphism for 
DEA 1 in the region of the CFA27 chromosome. Based 
on the findings of the immunoblotting tests and reactions 
with various monoclonal and polyclonal antibodies, 
Lee et al. (2017) suggested that the blood types Kai 1 and 
Kai 2 correspond to the proteins originally described as 
DEA 1.1 and DEA 1.2 and that the current monoclonal 
antibody DEA 1 recognizes a single erythrocyte antigen. 
These studies demonstrated that when polyclonal antibodies 
are used in the same way as in the present investigation, it 
is possible to find these three intensities of positivity as the 
authors described above as much as with the monoclonal 
antibodies, since it is a single blood group that is an autosomal 
dominant allelic system with the DEA 1 negative type and 
its variations of positivity.
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The typification for DEA 1 antigen through flow cytometry 
should offer more reliability to routine immunohematology 
in donor and recipient dogs. This method has therefore 
been proposed as a gold standard within blood typing, 
ensuring more accuracy and reliability of such procedures.
Conclusions
The flow cytometry using polyclonal antibody for the blood 
typing of the DEA 1 group is an accurate technique with clear 
differentiation between the positive and negative results.
Among the positive individuals for the AEC group 1, 
typified by flow cytometry, there are medium intensities 
of fluorescence which are indicative of weak, moderate 
and strong antigenicity which can help to divide the 
AEC group 1 into weak positive, moderate positive and 
strong positive.
The blood typing techniques for the AEC group 1 by flow 
cytometry, agglutination and immunochromatography had 
a positive correlation (Spearman r = 0.70) and a statistically 
significant correlation (p <0.0001).
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